Semax Peptide: What It Is, Uses, and the Evidence

What Is Semax?

Semax Explore PeRxSemax/SelankCognitive Clarity & Calm FocusView peptide is a lab-made peptide seven amino acids long. Its design starts from ACTH, the pituitary hormone that tells your adrenal glands to release cortisol. Researchers noticed decades ago that short pieces of ACTH changed learning and attention in animals without touching the adrenal glands at all. The stretch numbered 4 through 10 carried most of that effect, but it did not survive long in the bloodstream.

Chemists at the Institute of Molecular Genetics in Moscow kept the first four amino acids of that fragment, Met-Glu-His-Phe, and swapped the last three for Pro-Gly-Pro, a tail that slows the enzymes that chew peptides apart. The result is Semax. The FDA describes it as "devoid of the hormonal corticotropic and melanotropic properties" of ACTH, meaning it does not raise cortisol and does not darken skin. In 1997 its designers published a retrospective covering fifteen years of work on the molecule, which dates the project to the early 1980s.

Its regulatory and commercial life has been almost entirely Russian. Semax is a registered drug there, dispensed as 0.1% and 1% nasal drops, and Russian neurologists have used it for stroke, circulation-related cognitive decline, and optic nerve disease. It is not an FDA-approved drug. Search for it in the United States and the first page is journal abstracts and chemical supply catalogs, a fair picture of a molecule well known to a small research community and barely tested anywhere else. Our overview of nootropic peptides for brain health Read nextNootropic Peptides for Brain Health (2026)Nootropic is a broad word that covers everything from a cup of coffee to a prescription molecule. This guide narrows it to the peptides people actually ask about for cognition, calm, and sleep. What the research supports, what it does not yet support, and how Semax, Selank, Pinealon, and DSIP differ from one another.Read article places Semax next to the other cognitive peptides.

What Does Semax Do?

Nearly everything known about how Semax works comes from rats and mice. The finding reported most often involves BDNF, brain-derived neurotrophic factor, a protein that supports the strengthening of connections between neurons during learning. In 2006 Dolotov and colleagues gave rats a single intranasal dose of 50 micrograms per kilogram and measured a 1.4-fold rise in BDNF protein in the hippocampus, along with a 1.6-fold rise in activation of trkB, the receptor BDNF acts through. The treated animals also learned an avoidance task faster.

Dolotov OV, Karpenko EA, Inozemtseva LS, et al. "Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus." Brain Research, 2006;1117(1):54-60. View study

Eremin KO, Kudrin VS, Saransaari P, et al. "Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents." Neurochemical Research, 2005;30(12):1493-1500. View study

Two of those four matter later in this guide. The amphetamine finding is why stimulant prescriptions come up in screening, and the clotting finding is why blood thinners do. As for the big picture, FDA pharmacologists described Semax as acting "through poorly understood mechanisms of action." A plausible BDNF story in rats is a reason to study a molecule, not a description of what happens in your own head.

What Is Semax Peptide Used For, and What Does the Research Show?

The limitation comes first: we found no large randomized trial of Semax for anything, published in a form Western regulators could assess. What exists is a long list of rodent experiments, a Russian clinical literature of mostly small or open-label studies, and brain-imaging pilots in healthy volunteers. The table sorts the common claims by what sits underneath them.

Gusev EI, Skvortsova VI, Miasoedov NF, et al. "Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study)." Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 1997;97(6):26-34. In Russian. View study

Gusev EI, Martynov MY, Kostenko EV, et al. "The efficacy of semax in the treatment of patients at different stages of ischemic stroke." Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 2018;118(3 Vyp 2):61-68. In Russian. View study

Lebedeva IS, Panikratova YR, Sokolov OY, et al. "Effects of Semax on the Default Mode Network of the Brain." Bulletin of Experimental Biology and Medicine, 2018;165(5):653-656. View study

Three things make this record hard to lean on. Most of the clinical papers are in Russian with only an English abstract, so few readers can check the methods. The designs are weak by current standards: Semax added to standard care and compared, unblinded, against patients who did not get it. And one small circle of investigators, centered on the institute that invented the molecule, appears on most of the papers. None of that proves the findings wrong. It means nobody independent has repeated them, and repetition is how medicine tells a real effect from a hopeful one.

ADHD deserves a direct answer because so many people search it. The paper behind most online claims is a short 2007 hypothesis by Tsai, arguing that because Semax raises BDNF and amplifies stimulant-driven dopamine release in rodents, it might be worth testing in ADHD. Nobody ran that test. When the FDA looked at Semax for ADHD in 2026 it set the use aside because "supporting literature for this use was not found."

Tsai SJ. "Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome." Medical Hypotheses, 2007;68(5):1144-1146. View study

Alzheimer's Drug Discovery Foundation. "Semax." Cognitive Vitality Report for researchers, June 2020. View study

Nasal Research, Injected Prescription: The Route Question

Almost every human dose of Semax in the published record went up the nose, and the rat data explain why. Radiolabeled Semax given intranasally reached the brain within two minutes, in amounts several times higher than after an intravenous injection of the same dose, most likely by traveling along the olfactory nerve. Either way the share was tiny, well under a tenth of one percent of the dose, and the peptide was broken down quickly, leaving the fragment Pro-Gly-Pro as the main remnant.

Shevchenko KV, Nagaev IIu, Alfeeva LIu, et al. "Kinetics of Semax penetration into the brain and blood of rats after its intranasal administration." Bioorganicheskaia Khimiia, 2006;32(1):64-70. In Russian. View study

Here is the uncomfortable part for any clinic that prescribes injected Semax, ours included. The FDA reviewers were "unable to find literature that discussed administration via subcutaneous injection" in people, and found no animal study of how Semax behaves after a subcutaneous dose either. Many rodent experiments did use injections into the abdomen, the amphetamine study among them, so injected Semax plainly does something in a rodent brain. But nobody has measured blood levels, brain delivery, or duration after a subcutaneous injection in a person, and results from one route do not transfer automatically to another.

Why inject it, then? Nothing PeRx sells is intranasal. We prescribe Semax only as part of a Semax/Selank vial that a US 503A pharmacy compounds as a sterile solution at a fixed concentration, so a dose is a volume you can read on a syringe. A nasal product adds a second variable, the pump. The FDA said it "would have strong concerns" about a compounded Semax nasal spray because nothing is known about how a container and pump would be chosen to deliver a consistent dose. The trade is real: injection buys measured dosing and a sterile product, and gives up the nose-to-brain shortcut the original research was built around. Where to inject Selank Read nextWhere to Inject Semax/Selank: Sites, Rotation, TimingPeRx sells Selank as part of the Semax/Selank blend, a single vial given as a subcutaneous injection. Standalone intranasal Semax is a different product. This guide covers where to place the blend, how to rotate sites, and why morning timing matters, as of July 2026.Read article covers the practical side.

What FDA Reviewers Found in 2026

Ahead of its July 2026 advisory meeting, FDA staff wrote a roughly fifty-page evaluation of Semax, dated May 11, 2026. They searched PubMed, Embase, Cochrane, ClinicalTrials.gov and the FDA adverse event database. Their count of published human exposure they could assess: between 33 and 47 healthy adults, 69 adults with medical conditions, and 451 children in Russian studies of depression and tic disorders, several available only as conference abstracts. One paper reported no adverse events. The rest did not discuss adverse events at all.

They found no human pharmacokinetic study by any route. They found no acute toxicity, repeat-dose toxicity, or reproductive toxicity studies in animals. The adverse event database held a single report through December 3, 2025: a consumer who described eye pain and burning after using 0.1% nasal drops bought online. The Russian clinical papers did not count in the assessment, because FDA rules require a verified English translation of foreign-language material and none was supplied. That is a paperwork gap as much as a scientific one.

Three specific concerns stand out. The amphetamine result in mice raised a question about abuse potential that no study has addressed. The possible antithrombotic activity "raises concern about the risk of bleeding," particularly alongside other drugs that thin the blood. And like any injected peptide, Semax could provoke an immune response or clump into aggregates, a risk tied to impurities and manufacturing quality that nobody has tested for this molecule. On effectiveness, the conclusion was "insufficient evidence" for the three uses evaluated: reduced blood flow to the brain, migraine, and trigeminal nerve pain.

U.S. Food and Drug Administration. "FDA Briefing Document: Semax-Related Bulk Drug Substances (Semax (free base) and Semax acetate)." Pharmacy Compounding Advisory Committee, July 2026. Evaluation dated May 11, 2026. View study

Semax Side Effects and Who Gets Screened Out

With so little measured, any side-effect list for Semax is short and soft, and the only published rates come secondhand. The Alzheimer's Drug Discovery Foundation, citing a 2013 Russian review it could not check against original data, reports discoloration of the nasal lining in roughly 10% of patients using the drops and a rise in blood glucose in about 7.4% of patients with diabetes. The first is a nasal-route effect and does not apply to an injection. The second might, and it is on our intake for that reason. Long-term effects are unknown.

For the injected blend, what patients mention is ordinary: brief redness or soreness where the needle went in, and sometimes feeling wired or sleeping poorly if the dose is taken late in the day, which is why the blend is a morning injection. Those are reports, not measured rates, from a vial that also contains Selank. The screening below follows from the FDA findings and from mechanism: caution standing in for data.

Stop and contact a clinician for hives, swelling of the face or throat, or trouble breathing after a dose, for unusual bruising or bleeding, for a racing heart or agitation that does not settle, or for an injection site that gets redder, hotter, or more swollen after a day or two. PeRx prescribes only to adults 21 and older. Our peptide side effects guide Read nextPeptide Side Effects: Normal vs. Red Flag (2026)Most peptide side effects are mild local reactions that resolve in a day. A smaller set of systemic effects depends on the pathway the peptide acts on. And a third category, the one worth paying attention to, points to a problem with the product or the patient that should pause the protocol. Here is how to tell them apart.Read article covers the reactions common to all injected peptides.

What Is N-Acetyl Semax Amidate?

N-acetyl Semax amidate, often shortened to NA-Semax, is Semax with two chemical caps added: an acetyl group on the front end of the chain and an amide on the back end. Peptide chemists use both modifications to slow the enzymes that attack a chain from its ends, and research vendors sell this version, usually as a nasal spray, with claims that it is stronger or longer lasting than plain Semax.

Nothing published supports those claims. A PubMed search in September 2026 for N-acetyl Semax and its spelling variants returns zero papers, against more than 230 for Semax itself. The capped molecule is a different substance, so the Russian clinical record, thin as it is, does not belong to it, and the FDA evaluation covered Semax free base and Semax acetate only. One naming trap: Semax acetate is a salt form of ordinary Semax, while N-acetyl Semax is a modified molecule. PeRx does not sell N-acetyl Semax amidate in any form.

Why We Pair Semax With Selank

Semax is the activating half of a pair. In animal work it pushes toward alertness and drive, and patients describe it the same way. Selank, a separate Russian peptide built from an immune fragment called tuftsin, has been studied for the opposite problem, anxiety, with a calming effect that does not sedate. If you are trying to work out which of the two you actually need, Semax vs Selank Read nextSemax vs Selank: Which One Do You Actually Need?Every page ranking for this question tells you to pick one: Semax for focus, Selank for calm. The split is useful and softer than the marketing admits. Here is what the single human head-to-head found, where the two run on the same machinery, where the FDA record splits them, and why a prescribing clinic puts both in one vial instead of making you choose.Read article takes that apart. People rarely come to us wanting sharper focus alone. They want to think clearly under pressure, and the pressure is usually the larger half of the problem. Adding drive to an already anxious nervous system is a poor fit for that person, which is why we prescribe the two together and do not offer Semax alone.

The practical reason is simpler: one vial, one morning injection, one set of screening questions. The full case for the combination, including the Selank anxiety trial, is in our Selank and Semax guide Read nextSelank Peptide: What It Is, What It Does & BenefitsYour immune system already makes a molecule that calms anxiety. Soviet scientists found it in the 1970s, reverse-engineered it, and created two peptides: one that quiets anxiety without sedation, and another that sharpens cognition through BDNF. Both have been prescription medications in Russia since 2009. Combined in a single injectable blend, Selank and Semax cover both sides of the equation: calm and sharp at the same time.Read article , and peptides for anxiety Read nextPeptides for Anxiety: What Works and What's HypeSelank and Semax get talked about as natural anxiety fixes. The reality is more interesting than the skeptics assume and less proven than the enthusiasts claim. Here is which peptides are actually studied for anxiety, what the evidence shows, and how they compare to the medications you already know.Read article weighs it against conventional options. If sleep and longer-horizon brain health interest you more than daytime focus, the other Selank-containing blend is covered in what is Pinealon Read nextPinealon Peptide: What It Is, Evidence and DosingPinealon is three amino acids long, comes from one research institute in St. Petersburg, and is sold with a confidence its evidence does not support. Here is what the peptide actually is, why its name points at the wrong gland, what about twenty published studies do and do not show, why the dosing charts online disagree, and why we only prescribe it as one part of a three-peptide blend.Read article and the Pinealon/PE-22-28/Selank guide Read nextPinealon, PE-22-28 & Selank Guide (2026)Three peptides, three layers of brain support. Pinealon restores sleep architecture through pineal gland regulation. PE-22-28 drives neurogenesis by blocking the TREK-1 potassium channel. Selank calms anxiety through GABA modulation without sedation or dependence. Together they rebuild, grow, and protect neural tissue from three independent angles.Read article .

How Semax Is Prescribed at PeRx

Most Semax sold online in the United States comes from research suppliers: vials and nasal sprays labeled not for human use, with no prescription, no screening, and no way to confirm which form of Semax is inside or whether it was tested for endotoxins, the bacterial residue that matters most in anything injected. The FDA noted that none of the seller websites it examined said whether the product was the base, a salt, or something else. Research peptides vs prescription peptides Read nextResearch Peptides vs Prescription Peptides (2026)An honest comparison for the patient who already uses peptides, what the 'Not for Human Use' label actually means, the real quality differences, and the practical steps to switch from research-chemical sourcing to a prescription supply.Read article explains how far apart those two supply chains are, and how to read a peptide COA Read nextHow to Read a Peptide COAA Certificate of Analysis is the lab report behind a peptide vial. Learn to read one line by line: identity, purity, net peptide content, sterility, and endotoxin. Then learn the red flags that separate a real prescription COA from the screenshot a gray-market vendor pastes into a product page.Read article shows what a certificate should cover.

Semax/Selank

The only form of Semax PeRx prescribes: Semax and Selank together in one 5 mL vial, 1 mg/mL of each, compounded by a US 503A pharmacy. It is a subcutaneous injection taken in the morning. The vial ships fully reconstituted and ready to use, packed cold, with syringes and alcohol swabs in the box.

From $299 for a one-month supply. You complete an online intake, a licensed provider reviews it and prescribes the protocol if it fits, and your card is charged only after that approval. The dose is the one printed on your prescription label.

One vial, both peptides, injected under the skin. Not a nasal spray.

Shop Now

Semax: Common Questions